• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Resmed Inc (NY: RMD )

    242.04 -0.65 (-0.27%)
    Streaming Delayed Price Updated: 9:40 AM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Resmed Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From ResMed Inc.
    Via GlobeNewswire
    How Is The Market Feeling About ResMed?
    Via Benzinga
    $1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    RxSight Stock Sees Relative Strength Rating Rise To 91
    On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
    Via Investor's Business Daily
    Why Quality-Oriented Investors Should Consider NYSE:RMD.
    Exploring RESMED INC (NYSE:RMD)'s quality characteristics. 
    Via Chartmill
    NYSE:RMD may be ready to breakout.
    There are signs that NYSE:RMD may be ready to breakout. 
    Via Chartmill
    Uncovering Dividend Opportunities with NYSE:RMD.
    Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
    Via Chartmill
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
    Via Benzinga
    ResMed's Options Frenzy: What You Need to Know
    Via Benzinga
    ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
    From ResMed Inc.
    Via GlobeNewswire
    DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
    Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H.... 
    Via Benzinga
    ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
    ResMed reported Q4 2024 revenue of $1.22 billion, driven by strong demand for sleep devices and software services. Gross margin improved significantly due to reduced costs and higher selling prices.... 
    Via Benzinga
    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
    Via Benzinga
    What 6 Analyst Ratings Have To Say About ResMed
    Via Benzinga
    Looking Into ResMed's Recent Short Interest
    Via Benzinga
    ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
    From ResMed Inc.
    Via GlobeNewswire
    Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Stock Market News From Amazon, Nike, McCormick, and More
    We also talk with author Nicola Twilley about her new book, "Frostbite: How Refrigeration Changed Our Food, Our Planet, and Ourselves." 
    Via The Motley Fool
    Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
    Uncover key insights on stocks with negative analyst sentiment, including major moves by Alphabet, Nike and ResMed. 
    Via InvestorPlace
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
    Via Benzinga
    Is NYSE:RMD a Good Fit for Dividend Investing?
    Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD). 
    Via Chartmill
    ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
    From ResMed Inc.
    Via GlobeNewswire
    How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
    We also talk about weight loss drugs and sleep apnea, and other stock market news. 
    Via The Motley Fool
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
    Via MarketBeat
    Exposures Product Safety
    Beyond The Numbers: 6 Analysts Discuss ResMed Stock
    Via Benzinga
    Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
    The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments. 
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Why ResMed Shares Are Trading Lower Monday
    ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatment of sleep apnea. 
    Via Benzinga
    ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
    Wall Street faces a continuation of last week’s trend during Monday’s morning trading, with semiconductor stocks selling off heavily and dragging down the tech sector, while the broader market remains... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.